The FDA said it intends to hire “substantial numbers” of medical device review staff as part of the agreement for the next ...

A resilient medtech industry navigating the fallout from President Donald Trump’s trade wars is taking proactive steps to ...

The center plans to pick nine devices to help support patients and caregivers after a hospital stay.

The funding round follows high-profile acquisitions by Boston Scientific and Stryker to pick up mechanical thrombectomy ...

The company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal.

Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat ...

Using non-pneumatic nebulizers with the ventilators can lead to under-delivery of therapy to patients, the company said.

The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European ...

View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.

Jonathan Vigdorchik, an orthopedic surgeon from the Hospital for Special Surgery, previously was chief medical technology ...

Health regulators on both sides of the Atlantic are assessing alignment opportunities and exploring mutual recognition ...

The deal positions Boston Scientific to compete with Medtronic for a market that analysts believe is highly under-penetrated.